Background Worldwide, hepatocellular carcinoma (HCC) is a universal problem and its
epidemiological data showed variation from place to place. Hepatocellular carcinoma (HCC) …

An estimated 8–10 million people suffer from viral hepatitis in Egypt. Hepatitis A virus (HAV)
and hepatitis E virus (HEV) are the major causes of viral hepatitis in Egypt as 50% or more of …

Hepatocellular carcinoma (HCC) is the sixth most common primary malignancy worldwide,
and the third most common cause of death among cancers worldwide. HCC occurs in …

Background: In Egypt, there has been a remarkable increase in the proportion of
hepatocellular carcinoma (HCC) among chronic liver diseases patients. This rising …

Ultrasound‐based surveillance has suboptimal sensitivity for early detection of
hepatocellular carcinoma (HCC) in patients with cirrhosis. There are several emerging …

Hepatocellular carcinoma (HCC) is a disease of global public health significance with
mortality on the rise, despite the preventable nature of its risk factors especially in Africa. It is …

OBJECTIVE: This study aims to explore the rule of changes in serum GGT activity, as well as
GGT/ALT and AST/ALT ratios, in primary hepatic carcinoma (PHC) patients with different …

MicroRNAs (miRNAs) play important roles in liver pathologies and they are potential
biomarkers for diagnosis of liver diseases progression. Changes in miRNA sera expression …

Aim: The aim was to investigate the expression profile of miR-516a-3P and its correlation
with the PNPLA3 rs738409 polymorphism in Egyptian hepatitis C virus (HCV) and …

Background: The expression of programmed cell death ligands on tumor cells has a role in
the suppression of antitumor immunity, resulting in tumor immune evasion. Objective: In this …